As described in the Methods section, we devised methods to determine the ratios of mutant to WT alleles for the two most frequent mutations, deletions in exon 19 and the L858R mutation in exon 21, which together account for ∼85% of EGFR mutations in NSCLC [9]. Here, EGFR is linked to non-small cell lung carcinoma.